BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
4.180
-0.340 (-7.52%)
At close: Mar 20, 2026, 4:00 PM EDT
4.470
+0.290 (6.94%)
After-hours: Mar 20, 2026, 6:39 PM EDT
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $32.73 million as of March 20, 2026. Its market cap has increased by 224.03% in one year.
Market Cap
32.73M
Enterprise Value
2.45M
1-Year Change
224.03%
Ranking
Category
Stock Price
$4.18
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has increased from $26.00M to $32.73M, an increase of 25.87%. That is a compound annual growth rate of 4.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 32.80M | 144.78% |
| Dec 31, 2025 | 13.40M | -46.40% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
| Feb 24, 2021 | 26.00M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tvardi Therapeutics | 34.52M |
| Rein Therapeutics | 34.17M |
| Jasper Therapeutics | 34.14M |
| Actinium Pharmaceuticals | 34.00M |
| ABVC BioPharma | 32.82M |
| NovaBay Pharmaceuticals | 32.48M |
| INmune Bio | 32.43M |
| Pluri | 31.46M |